safingol has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auzenne, E; Feig, B; Hu, M; Klostergaard, J; Leroux, ME; Pollock, RE | 1 |
| Bodennec, J; Brichon, G; Portoukalian, J; Zwingelstein, G | 1 |
2 other study(ies) available for safingol and Malignant Melanoma
| Article | Year |
|---|---|
Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro.
Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzophenanthridines; Carboxylic Acids; Cell Survival; Ceramides; Dose-Response Relationship, Drug; Fumonisins; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Melanoma; Melphalan; Phenanthridines; Protein Kinase C; Sarcoma; Signal Transduction; Sphingosine; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Purification of sphingolipid classes by solid-phase extraction with aminopropyl and weak cation exchanger cartridges.
Topics: Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Chromatography, Thin Layer; Glycosphingolipids; Humans; Melanoma; Solvents; Sphingolipids; Sphingosine | 2000 |